StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Biden administration is finalizing contracts with six compan

<< Previous

Bullboard Posts

Next >>

Comment by InvrsContrarianon Feb 09, 2021 4:14am

271 Views

Post# 32510120

RE:Biden administration is finalizing contracts with six compan

For those of yous who were worried that stagezero planned for covid testing to stay strong during 2021 and thought that this revenue would go away and make their MD&A plans messed up , well you were wrong, looks like steady income for the next few quarters. Time to test out our capacity for testing, an opportunity to trial test our machinery for Aristotle testing forthcoming. Imagine running full out with 3-5000$ Aristotle tests everyday all day after the covid testing has faded away. Ah such a far away wish.

WHATTHE1 wrote:
"NEW YORK – Members of the White House COVID-19 Response Team announced on Friday that the Biden administration is finalizing contracts with six companies to quickly increase domestic testing capability for at-home SARS-CoV-2 tests."

https://www.modernhealthcare.com/safety-quality/biden-administration-finalizing-six-contracts-increase-home-covid-testing